Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

RAKESH RANJAN

Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry

NPI
1073549606
CMS profile
849105
Location
MEDINA, OH

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$44,331.36

137 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

By paying entity

PY2023 · entire year · sorted by reported total

Page 2 of 3; records 51–100 of 137 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

RAKESH RANJAN

NPI 1073549606 · CMS profile ID 849105

Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Psychiatry

MEDINA, OH

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 3; records 51–100 of 137 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1073549606?year=2023&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
RAKESH RANJAN, NPI 1073549606, CMS profile ID 849105. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 137 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1073549606?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). RAKESH RANJAN, NPI 1073549606, CMS profile ID 849105. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 137 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1073549606?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
RAKESH RANJAN, NPI 1073549606, CMS profile ID 849105, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 3; records 51–100 of 137 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1073549606?year=2023&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

137 matching records · $44,331.36 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 137 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 137.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Teva Pharmaceuticals USA, Inc. $19.5309/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056667103 CMS
ABBVIE INC. $0.4309/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998197611 CMS
ABBVIE INC. $2.3209/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998197613 CMS
Teva Pharmaceuticals USA, Inc. $22.1909/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056667105 CMS
Teva Pharmaceuticals USA, Inc. $3,125.0009/21/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056667177 CMS
Supernus Pharmaceuticals, Inc. $20.2809/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053300273 CMS
Corium, LLC $16.9409/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 978253131 CMS
ABBVIE INC. $28.4409/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998197607 CMS
ABBVIE INC. $19.4409/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998197609 CMS
Axsome Therapeutics, Inc. $15.3009/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056205951 CMS
Indivior Inc. $10.5008/31/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1034259793 CMS
ITI, Inc. $14.4508/29/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040668863 CMS
Otsuka America Pharmaceutical, Inc. $16.3308/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014727133 CMS
Otsuka America Pharmaceutical, Inc. $2.6908/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014727145 CMS
Otsuka America Pharmaceutical, Inc. $17.9008/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014727159 CMS
Supernus Pharmaceuticals, Inc. $16.8008/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053300269 CMS
Janssen Pharmaceuticals, Inc $22.9708/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 987900175 CMS
Teva Pharmaceuticals USA, Inc. $14.5008/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056667097 CMS
ABBVIE INC. $6.9808/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998197605 CMS
Lundbeck LLC $23.0808/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1032327053 CMS
Otsuka America Pharmaceutical, Inc. $3.5007/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014727097 CMS
Otsuka America Pharmaceutical, Inc. $13.4207/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014727109 CMS
Otsuka America Pharmaceutical, Inc. $19.5407/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014727122 CMS
Teva Pharmaceuticals USA, Inc. $1,250.0007/27/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056667091 CMS
Otsuka America Pharmaceutical, Inc. $23.6107/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014727085 CMS
Vanda Pharmaceuticals Inc. $25.4507/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051538947 CMS
Lundbeck LLC $12.0907/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1032327037 CMS
Lundbeck LLC $1.0307/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1032327045 CMS
Janssen Pharmaceuticals, Inc $23.4807/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 987900183 CMS
Otsuka America Pharmaceutical, Inc. $19.2907/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014727073 CMS
Otsuka America Pharmaceutical, Inc. $2.1407/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014727051 CMS
Otsuka America Pharmaceutical, Inc. $0.9107/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014727063 CMS
Alkermes, Inc. $12.0106/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1022900741 CMS
Teva Pharmaceuticals USA, Inc. $13.7106/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056667059 CMS
Janssen Pharmaceuticals, Inc $23.9806/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 987900207 CMS
Otsuka America Pharmaceutical, Inc. $17.3606/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014727037 CMS
BioXcel Therapeutics, Inc. $42.5006/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1057518105 CMS
Alkermes, Inc. $5,750.0006/14/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1022952145 CMS
Indivior Inc. $9.6406/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1034259785 CMS
Janssen Pharmaceuticals, Inc $23.9805/31/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 987900199 CMS
Teva Pharmaceuticals USA, Inc. $36.0105/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056667121 CMS
Otsuka America Pharmaceutical, Inc. $18.2705/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014727013 CMS
Otsuka America Pharmaceutical, Inc. $21.1705/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014727031 CMS
Alkermes, Inc. $187.8005/13/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1022952147 CMS
Alkermes, Inc. $272.9305/13/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1022952149 CMS
Alkermes, Inc. $200.1605/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1022952151 CMS
Alkermes, Inc. $51.9905/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1022900739 CMS
Lundbeck LLC $22.6005/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1032327029 CMS
ABBVIE INC. $20.0005/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998197603 CMS
Teva Pharmaceuticals USA, Inc. $68.9305/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056667221 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $113,838.22 262
PY2020 $65,985.88 194
PY2021 $70,815.66 213
PY2022 $77,730.10 179
PY2023 $44,331.36 137
PY2024 $38,394.87 182
PY2025 $12,398.87 172

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $139,677.99 66
PY2024 Principal investigator $41,664.69 22
PY2023 Principal investigator $29,837.78 61
PY2022 Principal investigator $33,212.59 21
PY2021 Principal investigator $29,824.85 8
PY2020 Recipient $1,685.45 1
PY2020 Principal investigator $10,211.25 44
PY2019 Principal investigator $5,651.00 16

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

66 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $1,500.00 12/17/2025 Non-covered Recipient Entity
RAKESH RANJAN MD & ASSOCIATES INC
ITI-007-601 No dispute reported 06/30/2026 1242369153
Principal investigator 1 Vanda Pharmaceuticals Inc. $2,612.25 12/03/2025 Non-covered Recipient Entity
RAKESH RANJAN MD & ASSOCIATES
SAFETY AND TOLERABILITY OF OPEN-LABELED ILOPERIDONE IN ADOLESCENTS No dispute reported 06/30/2026 1232947071
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $571.24 10/13/2025 Non-covered Recipient Entity
RAKESH RANJAN MD & ASSOCIATES INC
ITI-007-421 No dispute reported 06/30/2026 1242363747
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $750.00 10/13/2025 Non-covered Recipient Entity
RAKESH RANJAN MD & ASSOCIATES INC
ITI-007-601 No dispute reported 06/30/2026 1242363763
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $5,000.00 10/13/2025 Non-covered Recipient Entity
RAKESH RANJAN MD & ASSOCIATES INC
ITI-007-601 No dispute reported 06/30/2026 1242363779
Principal investigator 1 LivaNova USA, Inc. $130.00 10/08/2025 Non-covered Recipient Entity
RAKESH RANJAN MD & ASSOCIATES INC
RECOVER No dispute reported 06/30/2026 1245556053
Principal investigator 1 LivaNova USA, Inc. $1,144.00 10/08/2025 Non-covered Recipient Entity
RAKESH RANJAN MD & ASSOCIATES INC
RECOVER No dispute reported 06/30/2026 1245556057
Principal investigator 1 LivaNova USA, Inc. $1,222.00 10/08/2025 Non-covered Recipient Entity
RAKESH RANJAN MD & ASSOCIATES INC
RECOVER No dispute reported 06/30/2026 1245556059
Principal investigator 1 LivaNova USA, Inc. $130.00 10/08/2025 Non-covered Recipient Entity
RAKESH RANJAN MD & ASSOCIATES INC
RECOVER No dispute reported 06/30/2026 1245556096
Principal investigator 1 Vanda Pharmaceuticals Inc. $884.25 10/08/2025 Non-covered Recipient Entity
RAKESH RANJAN MD & ASSOCIATES
SAFETY AND TOLERABILITY OF OPEN-LABELED ILOPERIDONE IN ADOLESCENTS No dispute reported 06/30/2026 1232946497
Principal investigator 1 Vanda Pharmaceuticals Inc. $2,720.25 09/12/2025 Non-covered Recipient Entity
RAKESH RANJAN MD & ASSOCIATES
SAFETY AND TOLERABILITY OF OPEN-LABELED ILOPERIDONE IN ADOLESCENTS No dispute reported 06/30/2026 1232946351
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $3,500.00 09/08/2025 Non-covered Recipient Entity
RAKESH RANJAN MD & ASSOCIATES INC
ITI-007-601 No dispute reported 06/30/2026 1242358652
Principal investigator 1 LivaNova USA, Inc. $403.00 08/09/2025 Non-covered Recipient Entity
RAKESH RANJAN MD & ASSOCIATES INC
RECOVER No dispute reported 06/30/2026 1245556063
Principal investigator 1 LivaNova USA, Inc. $273.00 08/09/2025 Non-covered Recipient Entity
RAKESH RANJAN MD & ASSOCIATES INC
RECOVER No dispute reported 06/30/2026 1245556068
Principal investigator 1 LivaNova USA, Inc. $130.00 08/09/2025 Non-covered Recipient Entity
RAKESH RANJAN MD & ASSOCIATES INC
RECOVER No dispute reported 06/30/2026 1245556071
Principal investigator 1 LivaNova USA, Inc. $1,222.00 08/09/2025 Non-covered Recipient Entity
RAKESH RANJAN MD & ASSOCIATES INC
RECOVER No dispute reported 06/30/2026 1245556075
Principal investigator 1 LivaNova USA, Inc. $273.00 08/09/2025 Non-covered Recipient Entity
RAKESH RANJAN MD & ASSOCIATES INC
RECOVER No dispute reported 06/30/2026 1245556087
Principal investigator 1 LivaNova USA, Inc. $403.00 08/09/2025 Non-covered Recipient Entity
RAKESH RANJAN MD & ASSOCIATES INC
RECOVER No dispute reported 06/30/2026 1245556091
Principal investigator 1 Vanda Pharmaceuticals Inc. $884.25 07/29/2025 Non-covered Recipient Entity
RAKESH RANJAN MD & ASSOCIATES
SAFETY AND TOLERABILITY OF OPEN-LABELED ILOPERIDONE IN ADOLESCENTS No dispute reported 06/30/2026 1232945993
Principal investigator 1 LivaNova USA, Inc. $1,345.00 07/22/2025 Non-covered Recipient Entity
Advarra, Inc. (Central IRB)
RECOVER: A PRospective, Multi-cEnter, Randomized Controlled Blinded Trial DemOnstrating the Safety and Effectiveness of VNS Therapy System as AdjunctivE Therapy Versus a No-Stimulation Control in Subjects With Treatment-Resistant Depression No dispute reported 06/30/2026 1245556891
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $100.00 07/07/2025 Non-covered Recipient Entity
RAKESH RANJAN MD & ASSOCIATES INC
ITI-007-421 No dispute reported 06/30/2026 1242352742
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $132.00 07/07/2025 Non-covered Recipient Entity
RAKESH RANJAN MD & ASSOCIATES INC
ITI-007-421 No dispute reported 06/30/2026 1242352744
Principal investigator 1 Vanda Pharmaceuticals Inc. $884.25 07/03/2025 Non-covered Recipient Entity
RAKESH RANJAN MD & ASSOCIATES
SAFETY AND TOLERABILITY OF OPEN-LABELED ILOPERIDONE IN ADOLESCENTS No dispute reported 06/30/2026 1232945649
Principal investigator 1 LivaNova USA, Inc. $90.00 06/17/2025 Non-covered Recipient Entity
Advarra, Inc. (Central IRB)
RECOVER: A PRospective, Multi-cEnter, Randomized Controlled Blinded Trial DemOnstrating the Safety and Effectiveness of VNS Therapy System as AdjunctivE Therapy Versus a No-Stimulation Control in Subjects With Treatment-Resistant Depression No dispute reported 06/30/2026 1245556721
Principal investigator 1 LivaNova USA, Inc. $104.00 06/10/2025 Non-covered Recipient Entity
RAKESH RANJAN MD & ASSOCIATES INC
RECOVER No dispute reported 06/30/2026 1245556011
Principal investigator 1 LivaNova USA, Inc. $214.50 06/10/2025 Non-covered Recipient Entity
RAKESH RANJAN MD & ASSOCIATES INC
RECOVER No dispute reported 06/30/2026 1245556015
Principal investigator 1 LivaNova USA, Inc. $793.00 06/10/2025 Non-covered Recipient Entity
RAKESH RANJAN MD & ASSOCIATES INC
RECOVER No dispute reported 06/30/2026 1245556018
Principal investigator 1 Vanda Pharmaceuticals Inc. $2,720.25 05/21/2025 Non-covered Recipient Entity
RAKESH RANJAN MD & ASSOCIATES
SAFETY AND TOLERABILITY OF OPEN-LABELED ILOPERIDONE IN ADOLESCENTS No dispute reported 06/30/2026 1232945437
Principal investigator 1 LivaNova USA, Inc. $71.50 05/09/2025 Non-covered Recipient Entity
RAKESH RANJAN MD & ASSOCIATES INC
RECOVER No dispute reported 06/30/2026 1245556022
Principal investigator 1 LivaNova USA, Inc. $2,392.00 05/09/2025 Non-covered Recipient Entity
RAKESH RANJAN MD & ASSOCIATES INC
RECOVER No dispute reported 06/30/2026 1245556026
Principal investigator 1 LivaNova USA, Inc. $130.00 05/09/2025 Non-covered Recipient Entity
RAKESH RANJAN MD & ASSOCIATES INC
RECOVER No dispute reported 06/30/2026 1245556029
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $9,198.00 05/07/2025 Non-covered Recipient Entity
RAKESH RANJAN MD & ASSOCIATES INC
ITI-007-601 No dispute reported 06/30/2026 1242345855
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $351.00 05/07/2025 Non-covered Recipient Entity
RAKESH RANJAN MD & ASSOCIATES INC
ITI-007-421 No dispute reported 06/30/2026 1242346801
Principal investigator 1 Otsuka Pharmaceutical Development & Commercialization, Inc. $1,000.00 04/24/2025 Non-covered Recipient Entity
RAKESH RANJAN MD & ASSOCIATES INC
A LONG-TERM, MULTICENTER, OPEN-LABEL STUDY TO EVALUATE THE SAFETY AND TOLERABILITY OF FLEXIBLE-DOSE BREXPIPRAZOLE AS MAINTENANCE TREATMENT IN ADOLESCENT PATIENTS WITH SCHIZOPHRENIA No dispute reported 06/30/2026 1225335843
Principal investigator 1 Vanda Pharmaceuticals Inc. $884.25 04/23/2025 Non-covered Recipient Entity
RAKESH RANJAN MD & ASSOCIATES
SAFETY AND TOLERABILITY OF OPEN-LABELED ILOPERIDONE IN ADOLESCENTS No dispute reported 06/30/2026 1232945250
Principal investigator 1 LivaNova USA, Inc. $71.50 04/08/2025 Non-covered Recipient Entity
RAKESH RANJAN MD & ASSOCIATES INC
RECOVER No dispute reported 06/30/2026 1245556191
Principal investigator 1 LivaNova USA, Inc. $2,392.00 04/08/2025 Non-covered Recipient Entity
RAKESH RANJAN MD & ASSOCIATES INC
RECOVER No dispute reported 06/30/2026 1245556194
Principal investigator 1 LivaNova USA, Inc. $130.00 04/08/2025 Non-covered Recipient Entity
RAKESH RANJAN MD & ASSOCIATES INC
RECOVER No dispute reported 06/30/2026 1245556199
Principal investigator 1 LivaNova USA, Inc. $2,392.00 04/08/2025 Non-covered Recipient Entity
RAKESH RANJAN MD & ASSOCIATES INC
RECOVER No dispute reported 06/30/2026 1245556204
Principal investigator 1 LivaNova USA, Inc. $71.50 04/08/2025 Non-covered Recipient Entity
RAKESH RANJAN MD & ASSOCIATES INC
RECOVER No dispute reported 06/30/2026 1245556209
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $2,941.00 04/04/2025 Non-covered Recipient Entity
RAKESH RANJAN MD & ASSOCIATES INC
ITI-007-421 No dispute reported 06/30/2026 1242339648
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $3,608.00 04/04/2025 Non-covered Recipient Entity
RAKESH RANJAN MD & ASSOCIATES INC
ITI-007-421 No dispute reported 06/30/2026 1242339650
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $2,941.00 04/04/2025 Non-covered Recipient Entity
RAKESH RANJAN MD & ASSOCIATES INC
ITI-007-421 No dispute reported 06/30/2026 1242339662
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $2,941.00 04/04/2025 Non-covered Recipient Entity
RAKESH RANJAN MD & ASSOCIATES INC
ITI-007-421 No dispute reported 06/30/2026 1242339664
Principal investigator 1 Vanda Pharmaceuticals Inc. $2,170.00 04/03/2025 Non-covered Recipient Entity
RAKESH RANJAN MD & ASSOCIATES
SAFETY AND TOLERABILITY OF OPEN-LABELED ILOPERIDONE IN ADOLESCENTS No dispute reported 06/30/2026 1232945041
Principal investigator 1 Vanda Pharmaceuticals Inc. $884.25 04/03/2025 Non-covered Recipient Entity
RAKESH RANJAN MD & ASSOCIATES
SAFETY AND TOLERABILITY OF OPEN-LABELED ILOPERIDONE IN ADOLESCENTS No dispute reported 06/30/2026 1232945045
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $5,371.00 03/10/2025 Non-covered Recipient Entity
RAKESH RANJAN MD & ASSOCIATES INC
ITI-007-421 No dispute reported 06/30/2026 1242334904
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $5,371.00 03/10/2025 Non-covered Recipient Entity
RAKESH RANJAN MD & ASSOCIATES INC
ITI-007-421 No dispute reported 06/30/2026 1242334906
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $5,371.00 03/10/2025 Non-covered Recipient Entity
RAKESH RANJAN MD & ASSOCIATES INC
ITI-007-421 No dispute reported 06/30/2026 1242334908
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,856.00 03/10/2025 Non-covered Recipient Entity
RAKESH RANJAN MD & ASSOCIATES INC
ITI-007-421 No dispute reported 06/30/2026 1242334910
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $2,941.00 03/10/2025 Non-covered Recipient Entity
RAKESH RANJAN MD & ASSOCIATES INC
ITI-007-421 No dispute reported 06/30/2026 1242334962
Principal investigator 1 LivaNova USA, Inc. $130.00 03/08/2025 Non-covered Recipient Entity
RAKESH RANJAN MD & ASSOCIATES INC
RECOVER No dispute reported 06/30/2026 1245556161
Principal investigator 1 Vanda Pharmaceuticals Inc. $5,447.25 02/25/2025 Non-covered Recipient Entity
RAKESH RANJAN MD & ASSOCIATES
SAFETY AND TOLERABILITY OF OPEN-LABELED ILOPERIDONE IN ADOLESCENTS No dispute reported 06/30/2026 1232944903
Principal investigator 1 Sumitomo Pharma America, Inc. $1,290.00 02/19/2025 Non-covered Recipient Entity
RAKESH RANJAN MD & ASSOCIATES INC
A 24-WEEK, OPEN-LABEL STUDY EVALUATING THE EFFECTIVENESS, SAFETY AND TOLERABILITY OF SEP-363856 IN SUBJECTS WITH SCHIZOPHRENIA SWITCHED FROM TYPICAL OR ATYPICAL ANTIPSYCHOTIC AGENTS OLE. No dispute reported 06/30/2026 1176627781
Principal investigator 1 Sumitomo Pharma America, Inc. $5,316.00 02/19/2025 Non-covered Recipient Entity
RAKESH RANJAN MD & ASSOCIATES INC
A 24-WEEK, OPEN-LABEL STUDY EVALUATING THE EFFECTIVENESS, SAFETY AND TOLERABILITY OF SEP-363856 IN SUBJECTS WITH SCHIZOPHRENIA SWITCHED FROM TYPICAL OR ATYPICAL ANTIPSYCHOTIC AGENTS OLE. No dispute reported 06/30/2026 1176627853
Principal investigator 1 Vanda Pharmaceuticals Inc. $884.25 02/12/2025 Non-covered Recipient Entity
RAKESH RANJAN MD & ASSOCIATES
SAFETY AND TOLERABILITY OF OPEN-LABELED ILOPERIDONE IN ADOLESCENTS No dispute reported 06/30/2026 1232944759
Principal investigator 1 LivaNova USA, Inc. $2,392.00 02/08/2025 Non-covered Recipient Entity
RAKESH RANJAN MD & ASSOCIATES INC
RECOVER No dispute reported 06/30/2026 1245556129
Principal investigator 1 LivaNova USA, Inc. $71.50 02/08/2025 Non-covered Recipient Entity
RAKESH RANJAN MD & ASSOCIATES INC
RECOVER No dispute reported 06/30/2026 1245556134
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $6,000.00 01/08/2025 Non-covered Recipient Entity
RAKESH RANJAN MD & ASSOCIATES INC
ITI-007-321 No dispute reported 06/30/2026 1242328334
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $9,198.00 01/08/2025 Non-covered Recipient Entity
RAKESH RANJAN MD & ASSOCIATES INC
ITI-007-321 No dispute reported 06/30/2026 1242328338
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $2,346.00 01/08/2025 Non-covered Recipient Entity
RAKESH RANJAN MD & ASSOCIATES INC
ITI-007-421 No dispute reported 06/30/2026 1242328456
Principal investigator 1 LivaNova USA, Inc. $1,222.00 01/08/2025 Non-covered Recipient Entity
RAKESH RANJAN MD & ASSOCIATES INC
RECOVER No dispute reported 06/30/2026 1245556123
Principal investigator 1 LivaNova USA, Inc. $130.00 01/08/2025 Non-covered Recipient Entity
RAKESH RANJAN MD & ASSOCIATES INC
RECOVER No dispute reported 06/30/2026 1245556127
Principal investigator 1 LivaNova USA, Inc. $130.00 01/08/2025 Non-covered Recipient Entity
RAKESH RANJAN MD & ASSOCIATES INC
RECOVER No dispute reported 06/30/2026 1245556138
Principal investigator 1 Vanda Pharmaceuticals Inc. $3,462.75 01/06/2025 Non-covered Recipient Entity
RAKESH RANJAN MD & ASSOCIATES
SAFETY AND TOLERABILITY OF OPEN-LABELED ILOPERIDONE IN ADOLESCENTS No dispute reported 06/30/2026 1232944504
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $13,044.00 01/03/2025 Non-covered Recipient Entity
Rakesh Ranjan MD And Associates, Inc
A Study to Assess Efficacy and Safety of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia (ARISE) No dispute reported 06/30/2026 1235994367